GH Research PLC
GHRS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.91 | -0.02 | 3.19 | -0.12 |
| FCF Yield | -11.62% | -11.08% | -5.19% | -1.27% |
| EV / EBITDA | -6.96 | -5.45 | -11.09 | -62.12 |
| Quality | ||||
| ROIC | -27.94% | -18.74% | -3.89% | -5.45% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.09 | 0.94 | 1.17 | 1.66 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -26.61% | -27.30% | -70.70% | -1,288.72% |
| Safety | ||||
| Net Debt / EBITDA | 2.64 | 1.88 | 5.42 | 18.35 |
| Interest Coverage | -70.08 | -57.02 | 0.00 | -1,677.78 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | -0.52 | 0.01 |
| Cash Conversion Cycle | -4,334.81 | -4,043.97 | -15,205.74 | 40,822.37 |